HHLA2: a potential biomarker and therapeutic target in endocrine-related cancer

HHLA2: a potential biomarker and therapeutic target in endocrine-related cancer

Purpose: Human endogenous retrovirus-H long terminal repeat-associating 2 (HHLA2), a member of the B7 family, is widely expressed across human cancers and is emerging as a promising immune checkpoint target for therapeutic development. This study aims to consolidate existing data on HHLA2 expression...

Full description

Saved in:
Bibliographic Details
Main Authors: Christiane Gruetzmacher, Bruna Sousa Pessoa, Flora Ladeira Craveiro, Marilena Nakaguma, Ericka Barbosa Trarbach, Rafael Loch Batista
Format: Article
Language:English
Published: Bioscientifica 2025-04-01
Series:Endocrine Oncology
Subjects:
hhla2
biomarker
therapeutic target
endocrine-related cancer
immune checkpoint
cancer immunotherapy
Online Access:https://eo.bioscientifica.com/view/journals/eo/5/1/EO-24-0034.xml
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items